Structure-Function Relationships of hPTH(1-34) Analogues : Modification of Position 12 and the C-Terminal Region, and hPTH/hPTHrP Hybrid Peptides
スポンサーリンク
概要
- 論文の詳細を見る
- 1995-10-01
著者
-
Fukuda Tsunehiko
Pharmaceutical Research Laboratories Ii Takeda Chemical Industries Ltd.
-
NAKAGAWA Shizue
Pharmaceutical Research Laboratories II, Takeda Chemical Industries, Ltd.
-
NAKAMURA Junko
Pharmaceutical Research Laboratories II, Takeda Chemical Industries, Ltd.
-
HAMANA Takumi
Pharmaceutical Research Laboratories II, Takeda Chemical Industries, Ltd.
-
KARINO Noriko
Pharmaceutical Research Laboratories II, Takeda Chemical Industries, Ltd.
-
KAWASE Masahiro
Pharmaceutical Research Laboratories II, Takeda Chemical Industries, Ltd.
-
TAKETOMI Shigehisa
Pharmaceutical Research Laboratories II, Takeda Chemical Industries, Ltd.
-
Karino Noriko
Pharmaceutical Research Laboratories Ii Takeda Chemical Industries Ltd.
-
Hamana Takumi
Pharmaceutical Research Laboratories Ii Takeda Chemical Industries Ltd.
-
Kawase Masahiro
Pharmaceutical Research Laboratories Ii Takeda Chemical Industries Ltd.
-
Nakagawa Shizue
Pharmaceutical Research Laboratories Ii Takeda Chemical Industries Ltd.
-
Taketomi Shigehisa
Pharmaceutical Research Laboratories Ii Takeda Chemical Industries Ltd.
-
Nakamura Junko
Pharmaceutical Research Laboratories Ii Takeda Chemical Industries Ltd.
-
Taketomi Shigehisa
Pharmaceutical Research Division Takeda Chemical Industries, Ltd.,
関連論文
- Structure-Function Relationships of hPTH(1-34) Analogues : Modification of Position 12 and the C-Terminal Region, and hPTH/hPTHrP Hybrid Peptides
- Studies on Disease-Modifying Antirheumatic Drugs. III. Bone Resorption Inhibitory Effects of Ethyl 4-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) and Related Compounds